Literature DB >> 15460189

Hepatitis C virus (HCV): prevalence in a gynecological urgent care clinic population.

J Adusumalli1, E A Bonney, L Odenat, D J Jamieson.   

Abstract

OBJECTIVE: To determine the prevalence of hepatitis C virus (HCV) among women seeking urgent gynecological care.
METHODS: Women were asked to complete a short self-assessment screening of HCV risk. Those answering yes to any of the screening questions were offered HCV testing and were asked to complete a more detailed questionnaire.
RESULTS: Among the 125 women who completed the screening questionnaire, 80% (100) answered yes to one or more of the screening questions. Of the 99 women who underwent testing, six (6.1%) were HCV seropositive; a history of injection drug use was the only finding associated with HCV seropositivity (R.R 9.7: 95% CI 1.90-49.40).
CONCLUSIONS: Women seeking urgent outpatient gynecological care, particularly those who are injection drug users, are at a substantial risk of HCV infection. A careful risk assessment should be completed in order to identify women who should be offered HCV testing.

Entities:  

Mesh:

Year:  2004        PMID: 15460189      PMCID: PMC1784588          DOI: 10.1080/1064744042000210393

Source DB:  PubMed          Journal:  Infect Dis Obstet Gynecol        ISSN: 1064-7449


  5 in total

1.  The prevalence of hepatitis C virus infection in the United States, 1988 through 1994.

Authors:  M J Alter; D Kruszon-Moran; O V Nainan; G M McQuillan; F Gao; L A Moyer; R A Kaslow; H S Margolis
Journal:  N Engl J Med       Date:  1999-08-19       Impact factor: 91.245

Review 2.  Hepatitis C virus infection in the United States.

Authors:  M J Alter
Journal:  J Hepatol       Date:  1999       Impact factor: 25.083

3.  Hepatitis C virus infection in young, low-income women: the role of sexually transmitted infection as a potential cofactor for HCV infection.

Authors:  Kimberly A Page-Shafer; Barbara Cahoon-Young; Jeffrey D Klausner; Scott Morrow; Fred Molitor; Juan Ruiz; Willi McFarland
Journal:  Am J Public Health       Date:  2002-04       Impact factor: 9.308

4.  Seroprevalence and risk factors for hepatitis C virus antibody in pregnant women.

Authors:  V R Bohman; R W Stettler; B B Little; G D Wendel; L J Sutor; F G Cunningham
Journal:  Obstet Gynecol       Date:  1992-10       Impact factor: 7.661

5.  Sporadic non-A, non-B hepatitis: frequency and epidemiology in an urban U.S. population.

Authors:  M J Alter; R J Gerety; L A Smallwood; R E Sampliner; E Tabor; F Deinhardt; G Frösner; G M Matanoski
Journal:  J Infect Dis       Date:  1982-06       Impact factor: 5.226

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.